Home Stock

Stock Research: Syndax Pharmaceuticals

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Syndax Pharmaceuticals

NSQ:SNDX US87164F1057
82
  • Value
    100
  • Growth
    66
  • Safety
    Safety
    45
  • Combined
    64
  • Sentiment
    61
  • 360° View
    360° View
    82
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

more

ANALYSIS: With an Obermatt 360° View of 82 (better than 82% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Syndax Pharmaceuticals are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Syndax Pharmaceuticals. The consolidated Value Rank has an attractive rank of 100, which means that the share price of Syndax Pharmaceuticals is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 100% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 66, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 61. But the company’s financing is risky with a Safety rank of 45. This means 55% of comparable companies have a safer financing structure than Syndax Pharmaceuticals. ...read more

more
Strongest Rank Leverage
Weakest Rank Value
Country USA
Industry Biotechnology
Size Small
Website syndax.com
Index
NASDAQ
Syndax Pharmaceuticals stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 n/a n/a n/a
Growth
66 n/a n/a n/a
Safety
Safety
45 n/a n/a n/a
Sentiment
61 n/a n/a n/a
360° View
360° View
82 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
69 n/a n/a n/a
Opinions Change
18 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
30 n/a n/a n/a
Sentiment
61 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 n/a n/a n/a
Growth
66 n/a n/a n/a
Safety Safety
45 n/a n/a n/a
Combined
64 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
82 n/a n/a n/a
Price vs. Earnings (P/E)
83 n/a n/a n/a
Price vs. Book (P/B)
95 n/a n/a n/a
Dividend Yield
n/a n/a n/a n/a
Value
100 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
81 n/a n/a n/a
Profit Growth
38 n/a n/a n/a
Capital Growth
58 n/a n/a n/a
Stock Returns
61 n/a n/a n/a
Growth
66 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
7 n/a n/a n/a
Refinancing
91 n/a n/a n/a
Liquidity
60 n/a n/a n/a
Safety Safety
45 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Syndax Pharmaceuticals and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Peabody Energy

NYQ:BTU
Country: USA
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Innoviva

NSQ:INVA
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews